225 related articles for article (PubMed ID: 36374962)
1. Melatonin: A Potential Antineoplastic Agent in Breast Cancer.
Samanta S
J Environ Pathol Toxicol Oncol; 2022; 41(4):55-84. PubMed ID: 36374962
[TBL] [Abstract][Full Text] [Related]
2. The Potential Oncostatic Effects of Melatonin against Prostate Cancer.
Samanta S
Crit Rev Oncog; 2021; 26(3):53-67. PubMed ID: 35377986
[TBL] [Abstract][Full Text] [Related]
3. Melatonin: an endogenous miraculous indolamine, fights against cancer progression.
Samanta S
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1893-1922. PubMed ID: 32583237
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic actions of melatonin in cancer: possible mechanisms.
Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
[TBL] [Abstract][Full Text] [Related]
5. Melatonin: pharmacological aspects and clinical trends.
Rios ER; Venâncio ET; Rocha NF; Woods DJ; Vasconcelos S; Macedo D; Sousa FC; Fonteles MM
Int J Neurosci; 2010 Sep; 120(9):583-90. PubMed ID: 20707632
[TBL] [Abstract][Full Text] [Related]
6. Melatonin and its ubiquitous anticancer effects.
Bhattacharya S; Patel KK; Dehari D; Agrawal AK; Singh S
Mol Cell Biochem; 2019 Dec; 462(1-2):133-155. PubMed ID: 31451998
[TBL] [Abstract][Full Text] [Related]
7. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia.
Kilic U; Yilmaz B; Ugur M; Yüksel A; Reiter RJ; Hermann DM; Kilic E
J Pineal Res; 2012 Mar; 52(2):228-35. PubMed ID: 21913972
[TBL] [Abstract][Full Text] [Related]
8. Perioperative melatonin use.
Jarratt J
Anaesth Intensive Care; 2011 Mar; 39(2):171-81. PubMed ID: 21485664
[TBL] [Abstract][Full Text] [Related]
9. A Review on Melatonin's Effects in Cancer: Potential Mechanisms.
Hanikoglu A; Kucuksayan E; Akduman RC; Ozben T
Anticancer Agents Med Chem; 2018; 18(7):985-992. PubMed ID: 29173185
[TBL] [Abstract][Full Text] [Related]
10. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal.
Blask DE; Dauchy RT; Sauer LA
Endocrine; 2005 Jul; 27(2):179-88. PubMed ID: 16217131
[TBL] [Abstract][Full Text] [Related]
11. Physiological and pharmacological perspectives of melatonin.
Samanta S
Arch Physiol Biochem; 2022 Oct; 128(5):1346-1367. PubMed ID: 32520581
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Mechanical Perspective of a New Anti-Tumor Agent: Melatonin.
Rohilla S; Singh M; Priya S; Almalki WH; Haniffa SM; Subramaniyan V; Fuloria S; Fuloria NK; Sekar M; Singh SK; Jha NK; Chellappan DK; Negi P; Dua K; Gupta G
J Environ Pathol Toxicol Oncol; 2023; 42(1):1-16. PubMed ID: 36734949
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of melatonin anticancer effects.
Hill SM; Frasch T; Xiang S; Yuan L; Duplessis T; Mao L
Integr Cancer Ther; 2009 Dec; 8(4):337-46. PubMed ID: 20050373
[TBL] [Abstract][Full Text] [Related]
14. Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women.
Blask DE; Dauchy RT; Brainard GC; Hanifin JP
Integr Cancer Ther; 2009 Dec; 8(4):347-53. PubMed ID: 20042410
[TBL] [Abstract][Full Text] [Related]
15. Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night.
Blask DE; Hill SM; Dauchy RT; Xiang S; Yuan L; Duplessis T; Mao L; Dauchy E; Sauer LA
J Pineal Res; 2011 Oct; 51(3):259-69. PubMed ID: 21605163
[TBL] [Abstract][Full Text] [Related]
16. Potential role of melatonin in prevention and treatment of lung cancer.
Ngai ZN; Chok KC; Ng KY; Koh RY; Chye SM
Horm Mol Biol Clin Investig; 2022 Dec; 43(4):485-503. PubMed ID: 35728260
[TBL] [Abstract][Full Text] [Related]
17. Melatonin: an inhibitor of breast cancer.
Hill SM; Belancio VP; Dauchy RT; Xiang S; Brimer S; Mao L; Hauch A; Lundberg PW; Summers W; Yuan L; Frasch T; Blask DE
Endocr Relat Cancer; 2015 Jun; 22(3):R183-204. PubMed ID: 25876649
[TBL] [Abstract][Full Text] [Related]
18. [Melatonin. II. Physiological and therapeutic effects].
Bruls E; Crasson M; Van Reeth O; Legros JJ
Rev Med Liege; 2000 Sep; 55(9):862-70. PubMed ID: 11105602
[TBL] [Abstract][Full Text] [Related]
19. Prospects of the clinical utilization of melatonin.
Bubenik GA; Blask DE; Brown GM; Maestroni GJ; Pang SF; Reiter RJ; Viswanathan M; Zisapel N
Biol Signals Recept; 1998; 7(4):195-219. PubMed ID: 9730580
[TBL] [Abstract][Full Text] [Related]
20. Melatonin and mammary cancer: a short review.
Sánchez-Barceló EJ; Cos S; Fernández R; Mediavilla MD
Endocr Relat Cancer; 2003 Jun; 10(2):153-9. PubMed ID: 12790777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
